| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| DEXCOM INC | EVP Regulatory Strategy Clinic | Common Stock | 50.9K | $6.29M | $123.63 | Mar 10, 2023 | Direct |
| DEXCOM INC | EVP Regulatory Strategy Clinic | Common Stock | 30.2K | $3.74M | $123.63 | Mar 10, 2023 | by Trust |
| Glucotrack, Inc. | Director | Common Stock, par value $0.001 per share | 4.49K | $140K | $31.20 | Mar 26, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GCTK | Glucotrack, Inc. | Mar 26, 2025 | 1 | $0 | 4 | Mar 28, 2025 | Director |
| GCTK | Glucotrack, Inc. | Jun 14, 2024 | 0 | $0 | 3 | Mar 28, 2025 | Director |
| DXCM | DEXCOM INC | Mar 10, 2023 | 3 | -$1.3M | 4 | Mar 14, 2023 | EVP Regulatory Strategy Clinic |
| DXCM | DEXCOM INC | Mar 8, 2022 | 4 | -$1.39M | 4 | Mar 10, 2022 | EVP, Global Medical Affairs |
| DXCM | DEXCOM INC | Sep 9, 2021 | 12 | -$3.06M | 4 | Sep 13, 2021 | Officer |
| DXCM | DEXCOM INC | Aug 3, 2021 | 8 | -$1.42M | 4 | Aug 4, 2021 | Officer |
| DXCM | DEXCOM INC | Jul 6, 2021 | 4 | -$1.28M | 4 | Jul 8, 2021 | Officer |
| DXCM | DEXCOM INC | Jun 3, 2021 | 3 | -$897K | 4 | Jun 7, 2021 | Officer |